The interim results of the Vicctori trial (Vitamin D in Covid Cytokine storm therapy on registered inpatients) have been released, Vitamin D protects from the Covid-19 virus, but also prevents further progression of the disease.
On Monday, the Vice-Chancellor University of Health Sciences (UHS) Lahore and President Pakistan Society of Internal Medicine, Prof. Dr Javed Akram revealed the interim results of the Vicctori trial. He said: “We have conclusively shown through our trial that Vitamin D not only protects you from the Covid-19 virus but also prevents further progression of the disease”.
“Vitamin D is an inexpensive thing that people should be aware of,” he further added.
The results were released at the first UHS International conference on Covid-19, in the presence of Chief Guest Governor Punjab Chaudry Muhammad Sarwar, Justice (retd) Tassaduq HussainJilani, and CEO DRAP (Drug Regulatory Authority of Pakistan) Asim Rauf.
UHS and Scotmann Pharmaceuticals initiated the Vicctori trial in June 2020 which has shown promising results in the Covid-19 patients after Vitamin D therapy (SunnyD) was added as an adjunct to the conventional Covid-19 therapy.
Kristin Gustashaw, clinical dietitian at Rush University Medical Center in Chicago had also tested Vitamin D efficacy for coronavirus. “Part of the difficulty of maintaining vitamin D levels is because there are not a large variety of foods that contain much vitamin D,” Gustashaw said in a medical center news release.
Food sources include egg yolks, milk, cheese, beef or calf liver and certain fish, such as salmon, mackerel, tuna and sardines. Other foods are fortified with vitamin D, including certain cereals, breads, soy milk and orange juice.
Moreover, adults should get a minimum of 600 IU of vitamin D each day and 800 IU if over age 70. Children should get 600 IU each day. Whereas, infants up to the age of 12 months should get 400 IU/day. Gustashaw says you can determine your vitamin D levels through a blood test.